Results 151 to 160 of about 248,459 (305)

Structural and organisational impacts of peri‐operative enhanced care services in the UK: a Retrospective Evaluation of Postoperative Alternatives to Critical Care (REPACC)

open access: yesAnaesthesia, Volume 81, Issue 4, Page 500-512, April 2026.
Summary Introduction The enhanced care model of peri‐operative care has evolved to meet increasing surgical demand, aiming to relieve pressure on critical care and prevent unnecessary cancellation of surgery. Despite widespread adoption of these facilities in the UK, no resources currently describe the national landscape of enhanced care or the ...
Christopher Oddy   +330 more
wiley   +1 more source

Book Reviews

open access: yesNWIG, 1997
-Leslie G. Desmangles, Joan Dayan, Haiti, history, and the Gods. Berkeley: University of California Press, 1995. xxiii + 339 pp. -Barry Chevannes, James T. Houk, Spirits, blood, and drums: The Orisha religion in Trinidad.
Redactie KITLV
doaj  

Patient‐reported outcomes, postoperative pain and pain relief after day‐case surgery (POPPY): chronic post‐surgical pain prevalence and associations*

open access: yesAnaesthesia, Volume 81, Issue 4, Page 489-499, April 2026.
Summary Introduction Day‐case surgical activity is increasing in the UK yet there is a lack of data on the prevalence of chronic post‐surgical pain in this population. This study uses data from the POPPY study to estimate the prevalence of chronic post‐surgical pain after day‐case surgery, its relationship with quality of life and also explores ...
Adam B. Brayne   +2177 more
wiley   +1 more source

A user's guide to the NINDS rt-PA stroke trial database. [PDF]

open access: yesPLoS Medicine, 2008
Robert J Dachs   +2 more
doaj   +1 more source

International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 4, Page 2551-2565, April 2026.
Abstract Continuous glucose monitoring (CGM) is now central to diabetes management, yet variation in how respective medical products are evaluated limits meaningful comparison between CGM systems. Three barriers currently constrain reliable interpretation of glucose‐derived measures.
John S. Pemberton   +20 more
wiley   +1 more source

Home - About - Disclaimer - Privacy